MDLN
Get informed when a big investor buys or sells
+ FollowUndervalued by 54.3% based on the discounted cash flow analysis.
| Market cap | $30.39 Billion |
|---|---|
| Enterprise Value | $40.73 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.43 |
| Beta | -0.24 |
| Outstanding Shares | 819,000,000 |
| P/E Ratio | 30.53 |
|---|---|
| PEG | -50.73 |
| Price to Sales | 1.01 |
| Price to Book Ratio | 1.53 |
| Enterprise Value to Revenue | 1.4 |
| Enterprise Value to EBIT | 20.24 |
| Enterprise Value to Net Income | 42 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 1.12 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3879▼ 293.07% |
|---|---|
| Total Calls | 2,377,600▲ 444.20% |
| Total Puts | 922,302▼ 36.39% |
Holdings and activity of institutional investors.
| Ownership % | 78.39%▲ 5.98% |
|---|---|
| Total Invested | $28.31B▲ 18.24% |
| Investors Holding | 326▲ 117.00% |
No data
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medli...